Page 64 - Read Online

Page 20 of 21 Persico et al. Rare Dis Orphan Drugs J 2023;2:xx https://dx.doi.org/10.20517/rdodj.2023.08

38. Braconnier ML, Siper PM. Neuropsychological assessment in autism spectrum disorder. Curr Psychiatry Rep 2021;23:63. DOI
PubMed PMC
39. Jacquemont S, Berry-Kravis E, Hagerman R, et al. The challenges of clinical trials in fragile X syndrome. Psychopharmacology
2014;231:1237-50. DOI PubMed PMC
40. Sparrow SS, Cicchetti DV, Balla DA. Vineland adaptive behavior scales: second edition (Vineland II), survey interview form/
caregiver rating form. Livonia, MN: Pearson Assessments; 2005. DOI
41. Vaughan CA. Test Review: E. Schopler, M. E. Van Bourgondien, G. J. Wellman, & S. R. Love Childhood Autism Rating Scale (2nd
ed.). Los Angeles, CA: Western Psychological Services, 2010. J Psychoeduc Assess 2011;29:489-93. DOI
42. Guy W. Clinical global impressions ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute for
Mental Health; 1976. Available from: https://ia600306.us.archive.org/35/items/ecdeuassessmentm1933guyw/
ecdeuassessmentm1933guyw.pdf [Last accessed on 7 Jul2023].
43. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of likert and visual analogue scales for measuring change in function.
J Chronic Dis 1987;40:1129-33. DOI
44. Jaeschke R, Singer J, Guyatt GH. A comparison of seven-point and visual analogue scales. Data from a randomized trial. Control Clin
Trials 1990;11:43-51. DOI PubMed
45. Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983;40:1228-31. DOI
46. Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social
responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 2003;33:427-33. DOI
47. Lam KS, Aman MG. The repetitive behavior scale-revised: independent validation in individuals with autism spectrum disorders. J
Autism Dev Disord 2007;37:855-66. DOI PubMed
48. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment
effects. Am J Ment Defic 1985;89:485-91. PMID: 3993694. DOI PubMed
49. Tomchek SD, Dunn W. Sensory processing in children with and without autism: a comparative study using the short sensory profile.
Am J Occup Ther 2007;61:190-200. DOI PubMed
50. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and
criterion validity. J Abnorm Child Psychol 1998;26:257-68. DOI PubMed
51. Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms and profiles. Burlington, VT: University of Vermont, Research
Center for Children, Youth, and Families; 2000. Available from: https://www.researchgate.net/publication/
243771256_Manual_for_the_ASEBA_Preschool_forms_profiles [Last accessed on 7 Jul 2023].
52. Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington, VT: University of Vermont,
Research Center for Children, Youth, and Families; 2001. Available from: https://store.aseba.org/MANUAL-FOR-THE-ASEBA-
SCHOOL-AGE-FORMS-PROFILES/productinfo/505/ [Last accessed on 7 Jul2023].
53. McConachie H, Mason D, Parr JR, Garland D, Wilson C, Rodgers J. Enhancing the validity of a quality of life measure for autistic
people. J Autism Dev Disord 2018;48:1596-611. DOI PubMed PMC
54. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med
1998;28:551-8. DOI PubMed
55. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Wien, Austria; 2020.
56. Ponson L, Gomot M, Blanc R, et al. 22q13 deletion syndrome: communication disorder or autism? Transl Psychiatry 2018;8:146.
DOI PubMed PMC
57. Kann O, Kovács R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007;292:C641-57. DOI PubMed
58. Cheng A, Hou Y, Mattson MP. Mitochondria and neuroplasticity. ASN Neuro 2010;2:e00045. DOI PubMed PMC
59. Carmeli E, Imam B, Bachar A, Merrick J. Inflammation and oxidative stress as biomarkers of premature aging in persons with
intellectual disability. Res Dev Disabil 2012;33:369-75. DOI PubMed
60. Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual
disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci Biobehav Rev 2014;46 Pt
2:202-17. DOI PubMed
61. Alvarez-Mora MI, Rodriguez-Revenga L, Madrigal I, Guitart-Mampel M, Garrabou G, Milà M. Impaired mitochondrial function and
dynamics in the pathogenesis of FXTAS. Mol Neurobiol 2017;54:6896-902. DOI PubMed
62. Liu J, Wang L, Zhan S, Xia Y, Wang L. Coenzyme Q10 for Parkinson's disease. cochrane database of systematic reviews. Chichester:
John Wiley & Sons, Ltd 1996. DOI
63. Persico AM, Cucinotta F, Ricciardello A, Turriziani L. Autisms. Neurodevelopmental disorders. Elsevier; 2020. pp. 35-77. DOI
64. Rossignol DA, Frye RE. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals
with autism. Front Physiol 2014; 5:150. DOI PubMed PMC
65. Palmieri L, Persico AM. Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Biochim Biophys Acta 2010;
1797:1130-7. DOI PubMed
66. Palmieri L, Papaleo V, Porcelli V, et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and
genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 2010; 15:38-52. DOI